|
BARCODES WEST PARTNERS WITH WYNDGATE, A LEADING BLOOD BANK SOFTWARE COMPANY, TO PROVIDE COST-EFFECTIVE
ISBT 128 LABELING SOLUTION
Seattle, Washington – (November 14, 2008) - Barcodes West, LLC (BCW), a label, tag & marking industry leader, today announced a partnership agreement with Wyndgate Technologies® (Wyndgate) of El Dorado Hills, California, a division of Global Med Technologies, Inc., to offer ISBT 128 labeling products and LabelClinicTM software. LabelClinic medical software is an on-demand database and printing software for hospitals and blood banks that conforms to the ISBT-128 standard for blood product identification from the International Council for Commonality in Blood Banking Automation, Inc. (ICCBBA). Terms of the agreement were not disclosed.
“We are extremely excited to enter into a partnership with a premier provider of Blood Bank Information systems like Wyndgate Technologies” said Eric Peters, National Sales Manager for Barcodes West. “With the validation of LabelClinic software to Wyndgate’s Blood Bank products, Wyndgate is providing their customers an option to obtain a robust ISBT-128 labeling solution at a reasonable cost.”
Barcodes West offers a cost effective labeling, hardware and software solutions and has perfected the art of manufacturing labels that meet the various needs of the healthcare industry. Designed to perform under the most demanding applications, Barcodes West ISBT 128 labels are FDA cleared with a proven performance solution for medical and biological research industries, as well as blood banks and hospitals. Barcodes West is an active member of the American Association of Blood Bankers (AABB) and a registered ICCBBA member.
Wm. Scott Dustin, Senior Vice President of Sales and Marketing for Global Med Technologies, stated “In today’s economy we are pleased to be working with Barcodes West and Niceware to provide our customers with choices which empower them to maintain flexibility and quality while meeting their fiscal objectives.”
About Barcodes West, LLC
Barcodes West, LLC (BCW) is the label, tag & marking industry leader with combined experience of over 85 years providing high performance print, identification, & marking solutions to customers in over 35 countries around the globe. BCW combines technical and material expertise, industry knowledge, and personalized service to deliver the right solutions to help improve business productivity and image. Barcodes West's products are designed and produced in the U.S., providing digital photo-quality images, variable printing and the ability to manufacture barcode labels and tags to order.
About Niceware, International LLC
Niceware® International, LLC is a leading publisher of barcode and RFID software for healthcare and the automatic identification and data collection (AIDC) industry. Headquartered in Milwaukee, Wisconsin, Niceware is uniquely positioned to deliver high quality, feature rich software products combined with industry leading support and services to our valued partners. Niceware Healthcare is a business unit of Niceware International, LLC that operates with the philosophy of “Patient Safety through Positive Identification.” Niceware Healthcare is responsible for delivering flexible, high-performance software solutions to the healthcare industry to facilitate the positive identification of patients, blood and laboratory specimens.
About Global Med Technologies, Inc.
Global Med Technologies®, Inc. is an international medical software company which develops regulated and non-regulated software products and services for the healthcare industry. As a leading provider of blood and laboratory software applications and services, Global Med’s products are deployed in 20 countries and serve over 1,600 transfusion centers, blood banks and laboratories.
Global Med’s U.S. division, Wyndgate Technologies®, provides Vein-to-Vein® tracking through its Donor Doc™, SafeTrace®, SafeTrace Tx® and ElDorado Donor™ software products. Each year, Wyndgate’s products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply.
|